Reasons for Undertreatment with Oral Anticoagulants in Frail Geriatric Outpatients with Atrial Fibrillation: A Prospective, Descriptive Study

Author： Tulner Linda R.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.27, Iss.1, 2010-01, pp. : 39-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anticoagulation in atrial fibrillation: Vitamin K antagonists or new oral anticoagulants?

By Gilfrich Hans Joachim   Schott Gisela  

PHARMAKON, Vol. 1, Iss. 4, 2013-07 ,pp. : 313-319

Govi-Verlag

Access to resources Recommend Favorite

Digoxin and mortality in atrial fibrillation: a prospective cohort study

By Hallberg Pär   Lindbäck Johan   Lindahl Bertil   Stenestrand Ulf   Melhus Håkan  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 10, 2007-10 ,pp. : 959-971

Springer Publishing Company

Access to resources Recommend Favorite

Anticoagulants, renal failure and atrial fibrillation

By Genovesi Simonetta  

Expert Opinion on Drug Safety, Vol. 12, Iss. 1, 2013-01 ,pp. : 1-3

Informa Healthcare

Access to resources Recommend Favorite

Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves

By Marcy Todd R.   Truong Teresa   Rai Andrea  

The Consultant Pharmacist, Vol. 30, Iss. 11, 2015-11 ,pp. : 644-656

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants

By  

Current Pharmaceutical Design, Vol. 20, Iss. 39, 2014-12 ,pp. : 6096-6105

Bentham Science Publishers

Access to resources Recommend Favorite